Bafna Pharmaceuticals Limited(IN:BAFNAPH)
₹484.30-9.85 (-1.99%)
IN:BAFNAPH
Bafna Pharmaceuticals Limited financials statements
₹484.30
At close:-9.85 (-1.99%)
Want to see IN:BAFNAPH full AI Analyst Report?
Bafna Pharmaceuticals Limited (BAFNAPH) Income Statement
0 Followers
Bafna Pharmaceuticals Limited Income Statement
Last quarter (Q1 2027), Bafna Pharmaceuticals Limited's total revenue was ₹284.94M, a decrease of 17.70% from the same quarter last year. In Q1, Bafna Pharmaceuticals Limited's net income was ₹751.00K. See Bafna Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 1.51B | ₹ 1.46B | ₹ 1.52B | ₹ 1.15B | ₹ 851.40M | |
| ₹ 201.42M | ₹ 168.77M | ₹ 452.15M | ₹ 175.56M | ₹ 137.18M | |
| ₹ 102.67M | ₹ 105.89M | ₹ 214.49M | ₹ 71.63M | ₹ 272.51M | |
| Depreciation and Amortization | ₹ 60.73M | ₹ 48.90M | ₹ 49.95M | ₹ 53.34M | ₹ 54.93M |
| ₹ 207.04M | ₹ 117.73M | ₹ 146.34M | ₹ 189.88M | ₹ 112.34M | |
| ₹ 98.75M | ₹ 62.87M | ₹ 63.51M | ₹ 103.92M | ₹ 64.98M | |
| ₹ 10.95M | ₹ -21.35M | ₹ -164.18M | ₹ 12.24M | ₹ -12.82M | |
| ₹ 109.70M | ₹ 41.52M | ₹ 73.48M | ₹ 116.16M | ₹ 52.16M | |
| ₹ 111.00M | ₹ 41.52M | ₹ 73.48M | ₹ 113.38M | ₹ 52.16M | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 4.69 | ₹ 1.76 | ₹ 3.11 | ₹ 4.79 | ₹ 2.21 |
| Diluted EPS | ₹ 4.69 | ₹ 1.76 | ₹ 3.11 | ₹ 4.79 | ₹ 2.21 |
| Weighted Average Shares Outstanding | 23.67M | 23.69M | 23.63M | 23.66M | 23.66M |
| Weighted Average Shares Outstanding (Diluted) | 23.67M | 23.69M | 23.66M | 23.66M | 23.66M |
Currency in INR

